Please use this identifier to cite or link to this item: https://scholarhub.balamand.edu.lb/handle/uob/6838
Title: Mid-regional Proadrenomedullin Biomarker Predicts Coronavirus Disease 2019 Clinical Outcomes: A US-Based Cohort Study
Authors: Atallah, Natalie J
Panossian, Vahe S
Atallah, Christine J
Schwabe, Andrej
Johannes, Sascha
Wiemer, Jan
Mansour, Michael K
Affiliations: Faculty of Medicine 
Keywords: COVID-19
ICU
MR-proADM
Biomarkers; viral pneumonia
Issue Date: 2022-08-24
Part of: Open Forum Infectious Diseases
Volume: 9
Issue: 9
Abstract: 
Mid-regional proadrenomedullin (MR-proADM) is a biomarker released following endothelial damage. Studies have shown a correlation in predicting coronavirus disease 2019 (COVID-19) outcomes with MR-proADM levels. Our study aimed to investigate baseline MR-proADM as a predictor of a wider range of clinical outcomes of varying severity in patients admitted with COVID-19, and to compare to other biomarkers.
URI: https://scholarhub.balamand.edu.lb/handle/uob/6838
ISSN: 2328-8957
DOI: 10.1093/ofid/ofac423
Ezproxy URL: Link to full text
Type: Journal Article
Appears in Collections:Faculty of Medicine

Show full item record

SCOPUSTM   
Citations

2
checked on Apr 20, 2024

Record view(s)

19
checked on Apr 22, 2024

Google ScholarTM

Check

Dimensions Altmetric

Dimensions Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.